Deutsche Bank Ag\ Pliant Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,534,365 shares of PLRX stock, worth $20.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,534,365

Previous 1,526,164 0.54%

Holding current value

$20.4 Million

Previous $16.4 Million 4.84%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.52 - $14.35 $86,274 - $117,684	8,201 Added 0.54%	1,534,365 $17.2 Million
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $427,125 - $630,191	40,371 Added 2.72%	1,526,164 $16.4 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $7.08 Million - $9.81 Million	500,801 Added 50.84%	1,485,793 $22.1 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $7,414 - $11,049	-577 Reduced 0.06%	984,992 $17.8 Million
Q3 2023 Nov 09, 2023	SELL	$14.58 - $20.15 $4.45 Million - $6.15 Million	-305,083 Reduced 23.64%	985,569 $17.1 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $2.97 Million - $5.02 Million	164,123 Added 14.57%	1,290,652 $23.4 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $15.2 Million - $29.4 Million	811,221 Added 257.28%	1,126,529 $30 Million
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $113,730 - $170,126	6,690 Added 2.17%	315,308 $6.09 Million
Q2 2022 Aug 11, 2022	BUY	$4.11 - $8.75 $1.18 Million - $2.51 Million	286,831 Added 1316.52%	308,618 $2.47 Million
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $45,747 - $92,016	6,526 Added 42.76%	21,787 $153,000
Q4 2021 Feb 11, 2022	BUY	$12.27 - $18.26 $9,570 - $14,242	780 Added 5.39%	15,261 $206,000
Q3 2021 Nov 04, 2021	SELL	$16.48 - $28.98 $7,333 - $12,896	-445 Reduced 2.98%	14,481 $245,000
Q2 2021 Aug 11, 2021	SELL	$28.05 - $37.69 $23,814 - $31,998	-849 Reduced 5.38%	14,926 $435,000
Q1 2021 May 13, 2021	BUY	$24.52 - $40.23 $196,258 - $322,000	8,004 Added 103.0%	15,775 $620,000
Q4 2020 Feb 16, 2021	BUY	$19.89 - $32.99 $43,857 - $72,742	2,205 Added 39.62%	7,771 $177,000
Q3 2020 Nov 12, 2020	BUY	$21.54 - $29.53 $119,891 - $164,363	5,566 New	5,566 $126,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $647M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account